2011
DOI: 10.1097/qai.0b013e318235b378
|View full text |Cite
|
Sign up to set email alerts
|

Multisite Evaluation of a Point-of-Care Instrument for CD4+ T-Cell Enumeration Using Venous and Finger-Prick Blood

Abstract: PIMA is a good POC instrument for screening adult HIV-infected patients in resource-limited settings for treatment eligibility. Its performance on finger-prick blood is not as good as on venous blood. Adequate training for correct use of finger-prick blood samples is mandatory.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

15
86
1
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 72 publications
(103 citation statements)
references
References 13 publications
15
86
1
1
Order By: Relevance
“…Although cellular analyses typically require trained laboratory staff and central equipment such as flow cytometers, recent advances in microfluidics have made the development of accurate and affordable single-use chip devices a realistic option. [42][43][44] This promising technological progress is likely to allow routine monitoring of complex immune fingerprints in infected patients in the near future, suggesting that rapid differential biomarker-based diagnosis and guided management of noninfectious and infectious syndromes at the point of care are feasible.…”
Section: Discussionmentioning
confidence: 99%
“…Although cellular analyses typically require trained laboratory staff and central equipment such as flow cytometers, recent advances in microfluidics have made the development of accurate and affordable single-use chip devices a realistic option. [42][43][44] This promising technological progress is likely to allow routine monitoring of complex immune fingerprints in infected patients in the near future, suggesting that rapid differential biomarker-based diagnosis and guided management of noninfectious and infectious syndromes at the point of care are feasible.…”
Section: Discussionmentioning
confidence: 99%
“…Unfortunately, the price of each cartridge is quite high (approx. 6 USD per single use cartridge) and a high error frequency with aborted analysis of up to 14 % when used on capillary samples make the device less attractive in RSL as it increases cost further and requires higher educated staff (20) . In addition the analyzer cannot measure total lymphocyte counts, thus is not usable for monitoring in children where CD4 % are required.…”
Section: Hiv Diagnosis and Monitoringmentioning
confidence: 99%
“…In addition the analyzer cannot measure total lymphocyte counts, thus is not usable for monitoring in children where CD4 % are required. However, products under development such as the Daktari TM CD4 Counter (Daktari Diagnostics Inc., Cambridge, MA, USA), the MBio ™ Diagnostics CD4 system (MBio Diagnostics, Boulder, CO, USA), Zyomyx CD4 counter (Zyomyx, Hayward, CA, USA), the CD4 counter developed by the Burnet Institute (Melbourne, Australia) and the CD4 Point-of-Care Technology (BD Biosciences, Franklin Lakes, NJ, USA) may be promising alternatives and will also contribute to a competition on the CD4 point-of-care analyzer market with hopefully the effect of further price reductions to make CD4 cell monitoring widely available (20) .…”
Section: Hiv Diagnosis and Monitoringmentioning
confidence: 99%
“…For instance, the PointCare NOW TM and the CyFlow ® miniPOC are modified flow cytometers. PIMA TM is based on a dualfluorescence image analysis to count CD3 + /CD4 + cells (Diaw et al, 2011). The Coulter ® CD4Count Kit and the Dynal T4 Quant Kit are manual CD4 tests based on the use of beads for lymphocyte capturing, labeling and counting under light microscope (Lutwama et al, 2008).…”
Section: Introductionmentioning
confidence: 99%